Login / Signup

Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients.

Quan WuYujiao ZhangBaoyi YuanYun HuangLing JiangFang LiuPing YanJiaying ChengZhiquan LongXuejie Jiang
Published in: Cancer medicine (2024)
AML patients.
Keyphrases
  • acute myeloid leukemia
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • wild type
  • prognostic factors
  • gene expression
  • genome wide
  • patient reported